|
Market Closed -
OTC Markets
15:19:23 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.4300 USD | -1.60% |
|
-6.52% | -4.44% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.95M 1.78M 1.63M 3.07M 204M 3.16M 21.49M 8.57M 109M 8.16M 7.99M 344M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 12.09M 11.05M 10.09M 19.01M 1.27B 19.61M 133M 53.11M 676M 50.6M 49.52M 2.13B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -1.60% | ||
| 1 week | -6.52% | ||
| Current month | -29.50% | ||
| 1 month | -18.88% | ||
| 3 months | -12.24% | ||
| 6 months | +4.47% | ||
| Current year | -4.44% |
| 1 week | 0.43 |  | 0.52 |
| 1 month | 0.43 | | 0.78 |
| Current year | 0.23 | | 0.78 |
| 1 year | 0.23 | | 0.78 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 2022-06-15 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 2016-03-30 |
| Director of Finance/CFO | 46 | 2025-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 2015-01-26 |
David Mulder
BRD | Director/Board Member | 65 | 2016-05-16 |
Matthew Custer
BRD | Director/Board Member | 43 | 2022-06-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/12/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 8/28/25 | Free | Director | 50,000 | 0.6987% | ||
| 8/28/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.60% | -6.52% | +11.69% | -36.78% | 3.17M | |
| -0.79% | -4.48% | +44.44% | +127.49% | 1,216B | |
| +1.43% | +1.11% | +47.73% | +82.08% | 656B | |
| +1.07% | -1.21% | +32.99% | +106.31% | 509B | |
| -0.36% | -2.84% | +47.23% | +64.51% | 384B | |
| -0.14% | -1.87% | +71.05% | +40.63% | 362B | |
| -0.78% | +0.59% | +31.01% | +59.68% | 311B | |
| -0.80% | +6.73% | +11.89% | +35.64% | 293B | |
| +0.03% | -1.20% | +45.89% | +68.76% | 249B | |
| -0.41% | -2.22% | +35.24% | +105.68% | 208B | |
| Average | -0.50% | -2.30% | +37.92% | +65.40% | 418.78B | |
| Weighted average by Cap. | -0.58% | +0.03% | +42.47% | +88.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.69M 18.91M 17.26M 32.52M 2.17B 33.55M 228M 90.89M 1.16B 86.6M 84.74M 3.65B | 24.22M 21.72M 19.85M 18.12M 34.14M 2.28B 35.21M 239M 95.4M 1.21B 90.89M 88.94M 3.83B |
| Net income | -5.27M -4.72M -4.32M -3.94M -7.43M -495M -7.66M -52.04M -20.75M -264M -19.77M -19.35M -834M | -3.2M -2.87M -2.63M -2.4M -4.52M -301M -4.66M -31.65M -12.62M -161M -12.02M -11.76M -507M |
| Net Debt | 10.2M 9.15M 8.36M 7.63M 14.38M 959M 14.83M 101M 40.17M 511M 38.27M 37.45M 1.61B | 11.31M 10.14M 9.27M 8.46M 15.94M 1.06B 16.44M 112M 44.55M 567M 42.44M 41.53M 1.79B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$0.4300 | -1.60% | 800 |
| 26-11-05 | US$0.4370 | -2.89% | 10,007 |
| 26-11-04 | US$0.4500 | 0.00% | 5,900 |
| 26-11-03 | US$0.4500 | -2.17% | 2,919 |
| 26-11-02 | US$0.4600 | -24.58% | 6,024 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
